Participated in Syndex Bio's $15.5M seed financing led by ARCH Venture Partners.
Syndex Bio is a biotechnology company that has developed mcPCR, a novel platform technology for amplifying DNA methylation, enabling sensitive detection of diseases such as cancer
Syndex Bio is a biotechnology company that has developed mcPCR, a novel platform technology for amplifying DNA methylation, enabling sensitive detection of diseases such as cancer.